<DOC>
	<DOC>NCT01271452</DOC>
	<brief_summary>This study will evaluate the safety and efficacy of two different types of botulinum toxin type A for the treatment of glabellar frown lines.</brief_summary>
	<brief_title>Safety and Efficacy of Two Types of Botulinum Toxin Type A For the Treatment of Glabellar Lines</brief_title>
	<detailed_description />
	<mesh_term>Botulinum Toxins, Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Moderate to severe glabellar frown lines Diagnosis of myasthenia gravis or Eaton Lambert syndrome Aesthetic treatment with botulinum toxin within 6 months or planned treatment with botulinum toxin for any reason during the study Prior filler treatments, surgeries, insertion procedures in/to the glabellar region Facial cosmetic procedures in the glabellar area within 6 months Bleeding disorders or use of anticoagulants within 10 days History of facial nerve palsy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2011</verification_date>
</DOC>